Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma

The prognosis of esophageal cancer patients is still unsatisfactory. Although a docetaxel, cisplatin, and 5-Fu (DCF) regimen has been reported, it is often difficult to accomplish because of severe toxicity. Therefore, we developed a new biweekly DCF (Bi-DCF) regimen and previously reported the reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshihiro, Yoshida, Kazuhiro, Yamada, Atsuko, Tanahashi, Toshiyuki, Okumura, Naoki, Matsuhashi, Nobuhisa, Yamaguchi, Kazuya, Miyazaki, Tatsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882360/
https://www.ncbi.nlm.nih.gov/pubmed/26896963
http://dx.doi.org/10.1007/s00280-016-2985-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882360/
https://www.ncbi.nlm.nih.gov/pubmed/26896963
http://dx.doi.org/10.1007/s00280-016-2985-y

Ejemplares similares